Literature DB >> 29691174

Ten-Year Mortality and Revision After Total Knee Arthroplasty in Morbidly Obese Patients.

Mina Tohidi1, Susan B Brogly2, Katherine Lajkosz3, Heather J Grant4, Elizabeth G VanDenKerkhof5, Aaron R Campbell6.   

Abstract

BACKGROUND: Although morbid obesity has been associated with early surgical complications after total knee arthroplasty (TKA), evidence of long-term outcomes is limited. We conducted a population-based study to determine the association between morbid obesity and 10-year survival and revision surgery in patients undergoing primary TKA.
METHODS: A cohort study of 9817 patients aged 18-60 years treated with primary TKA from April 1, 2002 to March 31, 2007 was conducted using Ontario administrative health-care databases of universal health-care coverage. Patients were followed up for 10 years after TKA. Risk ratios (RRs) of mortality and TKA revision surgery in patients with body mass index > 45 kg/m2 (morbidly obese patients) compared with body mass index ≤45 kg/m2 (nonmorbidly obese) were estimated adjusting for age, sex, socioeconomic status, and comorbidities.
RESULTS: About 10.2% (1001) of the cohort was morbidly obese. Morbidly obese patients were more likely to be female than nonmorbidly obese patients (82.5% vs 63.7%, P < .001) but otherwise similar in characteristics. Morbidly obese patients had higher 10-year risk of death than nonmorbidly obese patients (adjusted RR 1.50, 95% confidence interval 1.22-1.85). About 8.5% (832) of the patients had at least 1 revision procedure in the 10 years after TKA; revision rates did not differ by obesity (adjusted RR 1.09, 95% confidence interval 0.88-1.34).
CONCLUSION: Morbidly obese patients ≤60 years had a 50% higher 10-year risk of death but no difference in the risk of revision surgery. Results of this population-based study inform evidence-based perioperative counseling of morbidly obese patients considering TKA.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arthroplasty; knee arthroplasty; mortality; obesity; revision surgery

Mesh:

Year:  2018        PMID: 29691174     DOI: 10.1016/j.arth.2018.03.049

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Ten-year risk of complication and mortality after total hip arthroplasty in morbidly obese patients: a population study

Authors:  Mina Tohidi; Susan B. Brogly; Katherine Lajkosz; Mark M. Harrison; Aaron R. Campbell; Elizabeth VanDenKerkhof; Stephen M. Mann
Journal:  Can J Surg       Date:  2019-12-01       Impact factor: 2.089

2.  Does body mass index affect the rate of adverse outcomes in total hip and knee arthroplasty? A retrospective review of a total joint replacement database

Authors:  Irfan Abdulla; Saboura Mahdavi; Hoa Khong; Richdeep Gill; James Powell; Kelly Dean Johnston; Rajrishi Sharma
Journal:  Can J Surg       Date:  2020-03-27       Impact factor: 2.089

3.  Weight and height separated provide better understanding than BMI on the risk of revision after total knee arthroplasty: report of 107,228 primary total knee arthroplasties from the Swedish Knee Arthroplasty Register 2009-2017.

Authors:  Erdem A Sezgin; Annette W-Dahl; Lars Lidgren; Otto Robertsson
Journal:  Acta Orthop       Date:  2019-11-08       Impact factor: 3.717

4.  Pain, Function, and Satisfaction After Total Knee Arthroplasty, with or Without Bariatric Surgery.

Authors:  Perna Ighani Arani; Per Wretenberg; Johan Ottosson; Annette W-Dahl
Journal:  Obes Surg       Date:  2022-01-27       Impact factor: 4.129

5.  Body Composition Changes in the Immediate Peri-operative Period Following Total Joint Arthroplasty.

Authors:  Michael C Marinier; Ayobami S Ogunsola; Jacob M Elkins
Journal:  J Electr Bioimpedance       Date:  2022-09-09

6.  Effect of morbid obesity on patient-reported outcomes in total joint arthroplasty: a minimum of 1-year follow-up.

Authors:  Mohamad J Halawi; Christian Gronbeck; Lawrence Savoy; Mark P Cote
Journal:  Arthroplast Today       Date:  2019-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.